NXEN (Nexien BioPharma) Total Operating Expense: $0.12 Mil (TTM As of Mar. 2025)


What is Nexien BioPharma Total Operating Expense?

Nexien BioPharma NXEN Total Operating Expense is $0.12 Mil as of Mar. 2025.

Nexien BioPharma's Total Operating Expense for the three months ended in Mar. 2025 was $0.01 Mil. Nexien BioPharma's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $0.12 Mil.

Nexien BioPharma Total Operating Expense Related Terms

Nexien BioPharma Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Nexien BioPharma's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexien BioPharma Total Operating Expense Chart

Nexien BioPharma Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Total Operating Expense
Get a 7-Day Free Trial 2.64 1.84 0.45 0.28 0.16

Nexien BioPharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.06 0.02 0.02 0.01

Nexien BioPharma Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $0.12 Mil mean?
Nexien BioPharma (NXEN) has a Total Operating Expense of $0.12 Mil as of Mar. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Nexien BioPharma and its competitors.
Is Nexien BioPharma's Total Operating Expense too high?
Nexien BioPharma's current Total Operating Expense is $0.12 Mil.
How does Nexien BioPharma's Total Operating Expense compare to FLHLF and ZTS?
Nexien BioPharma's Total Operating Expense of $0.12 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Nexien BioPharma and its competitors. Nexien BioPharma's current Total Operating Expense is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexien BioPharma stock overvalued right now?
Nexien BioPharma (NXEN) has a current Total Operating Expense of $0.12 Mil. The current Total Operating Expense is $0.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Nexien BioPharma (NXEN), the current Total Operating Expense is $0.12 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nexien BioPharma Business Description

Address 4340 East Kentucky Avenue, Suite 206, Glendale, CO, USA, 80246
Nexien BioPharma Inc is engaged in pre-clinical and drug development activities, by U.S. Food and Drug Administration (FDA) protocols, for certain pharmaceutical formulations that include cannabinoids. The company is pursuing the formulation and development of drugs containing cannabinoids for the treatment of various diseases, disorders, and medical conditions.